Phrixus Pharmaceuticals, Inc. develops and commercializes pharmaceuticval s and therapies related to heart failure. The company develops Carmeseal, a therapy for the treatment of heart failure. Phrixus Pharmaceuticals, Inc. was incorporated in 2006 and is based in Ann Arbor, Michigan.

from http://phrixuspharmaceuticals.com/

Research Grants 7 show all


$277.6K
2008

$379.4K
2009

$306.7K
2010

$583.2K
2011

$622.8K
2012

Patents 46show all

  • 36
    A61K - Preparations for medical, dental, or toilet purposes
  • 3
    A23L - Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses  -
  • 3
    A61Q - Specific use of cosmetics or similar toilet preparations
  • 3
    C07H - Sugars
  • 3
    C08B - Polysaccharides

Clinical Trials 3show all

2N/A1Phase 2

SEC Filings show all


2
D

Contact Information

1600 Huron Parkway Building 520, 2nd Floor
Ann Arbor, MI 48109
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$1,613,0001-102013-10-09Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2012-06-21$623,000Series Unknown
2013-10-09$100,000Debt Financing
2007-07-17Series UnknownAnn Arbor SPARK
2011-04-05$890,000Series Unknown

SEC Form D Funding Events

DateOfferedSoldType
2013-10-08$1,000,000$100,000Debt, Option to Acquire
2009-01-05Unknown Unknown Other (Paper Filing)

Key Executives

  • Thomas A Collet
    Executive Officer, Director
  • Gerald Brennan
    Director
  • Leslie Browne
    Director
  • Bruce Markham
    Director